Dr. Tony W Ho M.D.
Neurologist | Neurology
1800 Concord Pike Wilmington DE, 19897About
Dr. Tony Ho is a distinguished Neurologist in Wilmington, DE. Dr. Ho specializes in diagnosing, treating, and managing disorders of the brain and nervous system. With expertise in handling complex conditions like epilepsy, multiple sclerosis, and migraines, Dr. Ho employs advanced techniques and personalized treatment plans to improve patient outcomes. As a neurologist, Dr. Ho is committed to staying abreast of the latest developments in neurological research and therapies.
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Etiology, neurologic correlations, and prognosis in alpha coma.
- Autoantibodies to GM1b and GalNAc-GD1a: relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in China.
- Physiologic-pathologic correlation in Guillain-Barré syndrome in children.
- Sensitivity of the pendulum test for assessing spasticity in persons with cerebral palsy.
- Differential distribution of HLA-DQ beta/DR beta epitopes in the two forms of Guillain-Barré syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQ beta epitopes associated with suscep
- 50 kD prolactin binding protein in schizophrenics on neuroleptic medication.
- Prolactin isoform 2 as an autocrine growth factor for GH3 cells.
- Improving patient selection for clinical acute stroke trials.
- Preventing postoperative nausea and vomiting: post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant.
- Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies.
- A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine.
- Ten years of rizatriptan: from development to clinical science and future directions.
- Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adults.
- Impact of recent prior opioid use on rizatriptan efficacy. A post hoc pooled analysis.
Dr. Tony W Ho M.D.'s Practice location
Dr. Tony W Ho M.D.'s reviews
Write ReviewRecommended Articles
- Is There a Cure for Autism?
It is natural to ask your doctor about the cure for any disease once you have been diagnosed with it. The same is true for those diagnosed with autism. Unfortunately, there is no cure for autism.Various behavioral adjustment methods and medications that manage autism’s core symptoms are available...
- New Simulation Reveals Family Cost of Alzheimer's Disease
Approximately 5 million individuals in the United States suffer from dementia, Alzheimer’s disease, or another type of neurological disorder. Such conditions can be expensive to treat and sadly, the financial burden falls on the patients and their families as opposed to receiving help from...
- Reasons Why Lobotomies are Not Scientifcally Reliable
A lobotomy was performed approximately 80 years ago. This procedure was performed to cut through the so-called fixed circuits, which constricted the brain and made a person to behave abnormally. It was a technique used to cure psychiatric illnesses like depression, schizophrenia, and compulsive...
- Labyrinthitis and Vertigo
Labyrinthitis is an inflammation of the inner ear due to a virus or bacteria. This inflammation of the inner ear disrupts the transmission of the sensory information to the brain. When it happens, symptoms similar to those of vertigo may be experienced as well as difficulties in vision and hearing....
- Muscular Dystrophy: Combining Brain-Computer Interfaces and Assistive Technologies
With the development of modern computers and networks, assistive technologies (AT) for people with disabilities have changed a lot. Not only can one control the devices through the voice, indeed, most of the devices and appliances can be connected to the voice activation services. So one can change...
- New Multiple Sclerosis Treatment, Ocrevus, Slows Down Disease Progression
In 2017, the United States Food and Drug Administration (USFDA) approved the drug – Ocrevus (ocrelizumab) – as a treatment for both relapsing and progressive forms of multiple sclerosis. ...
Nearby Providers
- Douglas B. Gersh774 Christiana Road Newark Delaware 19713
- Dr. Carl R. Yacoub M.D.537 Stanton-Christiana Road Newark Delaware 19713
- Richard Racioppi DC6 Dickinson Dr Chadds Ford Pennsylvania 19317
- Dr. David Sirken DO1 Medical Center Blvd Chester PA 19013
- Dr. Charles Brill MDA.I. DUPONT HOSPITAL FOR CHILDREN WILMINGTON DE 19803
- Dr. Enrica Arnaudo MD200 Hygeia Dr Newark DE 19713